MedicaidCoverageMedium impact
KMAP BULLETIN: Preferred Drug List Update – March 2026
Kansas Medicaid (KanCare)·KS · Rheumatology, Neurology, OB-GYN +4 more·Pharmacy
Effective date
Mar 1, 2026
We identified it
Jun 21, 2026
Summary
KMAP updated their preferred drug list effective March 1, 2026, moving seven medications (including Cibinqo, Rinvoq, and Treximet) to non-preferred status and three medications (Brisdelle, Enoby, Xtrenbo) to preferred status. This affects prior authorization requirements and patient cost-sharing for Kansas Medicaid patients.
Action Required
Before March 1, 2026: Billing team must update prior authorization protocols for the seven newly non-preferred medications (Cibinqo, Lynkuet, Rinvoq, Symbravo, Treximet, Tryptyr, Veozah) for Kansas Medicaid patients. Update EMR alerts to notify providers of formulary changes. Monitor KanCare MCO implementation dates as they may vary from the March 1st effective date.